InaVein Announces Publication of Largest
LEXINGTON, Mass. – May 15, 2009 -- InaVein,
LLC announced today that the largest study to date on its TRIVEX
System for the removal of extensive varicose veins will be published
in the May/June 2009 issue of the peer-reviewed journal Annals
of Vascular Surgery. Authored by Randall W. Franz, M.D. and Eric
D. Knapp, D.O. from the Vascular and Vein Center at Grant Medical
Center, Columbus, OH, the study of 339 patients over a six-year
period reports a mean operative time of 19.7 minutes, no recurrences
at 12 weeks post-op follow-up, and 99.7% of patients reporting
a good outcome and satisfaction with the procedure.
InaVein, LLC is a privately held company engaged in the development,
manufacture, marketing and commercialization of unique medical
devices for the treatment of vein disease. The company’s
flagship product, The TRIVEX™ System, is the first technology
to provide surgeons with a minimally invasive technique to
remove varicose veins safely and efficiently under direct vision.
Since 2003, thousands of patients worldwide have been successfully
treated using The TRIVEX System to completely remove their
varicose veins. In addition, the company is developing other
vascular products to assist clinicians in treating the full
spectrum of conditions caused by peripheral venous disease.
For more information please
Vice President-Marketing and Sales